【作者】 吴锦波； 王志兵； 袁诚；

【Author】 WU Jin-bo;WANG Zhi-bing;YUAN Cheng;Department of Internal Medicine,Humen Hospital of TCM;

【机构】 东莞市虎门中医院内科；

【摘要】 目的:观察促红细胞生成素(erythropoietin,EPO)对慢性心力衰竭(chronic heart failure,CHF)患者生活质量和住院时间的影响。方法:将80例CHF患者随机分成常规治疗组(对照组)和试药组(各40例),记录治疗前后患者的明尼苏达心力衰竭生活质量评分,分析比较住院时间和再住院率。结果:试药组治疗前后生活质量评分的改善显著优于对照组(P<0.05),住院时间和再住院率均少于对照组(均P<0.05)。结论:EPO治疗CHF能显著提高患者生活质量,减少住院时间。更多还原

【Abstract】 AIM:To observe the effect of erythropoietin(EPO) on the quality of life and hospitalization time in patients with chronic heart failure(CHF).METHODS:Eighty CHF patients were randomly equally divided into two groups:40 patients in the control group treated with standard CHF medications and 40 patients in the EPO group treated with standard CHF medications plus EPO.The Minnesota Heart Failure Quality of Life Scale was measured before and after treatment and hospitalization days and rates of re-hospitalization were compared between groups.RESULTS:After treatment,improvement of the Minnesota Heart Failure Quality of Life Scale in EPO group was higher than in control group(P < 0.05) and days of hospitalization and rate of re-hospitalization in EPO group were lower than those in control group(all P <0.05).CONCLUSION:Treatment with EPO can improve quality of life and reduce hospitalization days and re-hospitalization rate in CHF patients.更多还原